Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Abstract Submission
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home

Resources

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 17/03/21 by David Breen

Pharmacist Led Myelopfoliferative Neoplasm Clinic An Audit of Current Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Ben Eliott

Exploring the assessment skills required by pharmacist independent prescribers for the safe prescribing of systemic anti-cancer therapy 

Abstracts

View resources
Last reviewed: 10/07/19 by Kate Wood

Proposal for the reduction in observation time post administration of subcutaneous Herceptin

Abstracts

View resources
Last reviewed: 10/07/19 by Natalie Ford

Observational Study of Skin Toxicity with Afatinib

Abstracts

View resources
Last reviewed: 10/07/19 by Natalie Ford

Is there Value in Using Patient Recorded Outcome Measures (PROMS) to Improve Toxicity Management Patients Receiving Chemotherapy for Breast Cancer?

Abstracts

View resources
Last reviewed: 10/07/19 by Faye Coe

Predictors for deferrals and dose reductions with Oxaliplatin Modified de Gramont chemotherapy (OXMDG) for colorectal cancer

Abstracts

View resources
Last reviewed: 10/07/19 by Adam Buckler

SACT dose banding at the Royal Marsden Hospital

Abstracts

View resources
Last reviewed: 10/07/19 by Hector Mateo-Carrasco

Incidence of neutropenia in breast cancer patients receiving fixed-dose GCSF: are we underdosing patients with higher body weights?

Abstracts

View resources
Last reviewed: 10/07/19 by Hector Mateo-Carrasco

Compared efficacy of palbociclib vs ribociclib in advanced breast cancer

Abstracts

View resources
Last reviewed: 10/07/19 by Anna Tipping

Pilot Audit for National Chemotherapy Delays

Abstracts

View resources
Last reviewed: 11/07/19 by Rajinder Nijjar

Managing Oral Systemic Anti-Cancer Therapies Quantifying Current Waste and Implementing Strategies to Reduce Waste

Abstracts

View resources
Last reviewed: 10/07/19 by Beth Hogdson

Patient Acceptability of National Chemo Dose Banding Leaflet

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 … 111 112 113 … 124 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.